Gerald N. Herman, Executive Vice President and Chief Financial Officer of Bruker Corporation, filed a statement of changes in beneficial ownership on August 13, 2026, disclosing a share withholding transaction dated August 11, 2026.

Key Highlights

  • Reporting person: Gerald N. Herman, Executive Vice President and CFO of Bruker Corporation (NASDAQ:BRKR)
  • Transaction type: 1,410 shares of common stock were disposed of under transaction code F at a price of $57.02 per share
  • Purpose of transaction: Shares were withheld by the company to satisfy tax withholding obligations upon the vesting of restricted stock units previously granted to Herman
  • Resulting ownership: Herman directly holds 98,284 shares of Bruker common stock following the transaction
  • Transaction date: August 11, 2026; filing signed August 13, 2026 by Betsy Eberg as Attorney-in-Fact

Bruker CFO's RSU Vesting and Tax Withholding Transaction Details

According to the filing, Gerald N. Herman, who serves as Executive Vice President and Chief Financial Officer at Bruker Corporation, reported a single non-derivative securities transaction involving common stock. The transaction, coded "F" under the applicable instructions, reflects shares withheld by Bruker Corporation itself rather than shares sold on the open market. Bruker Corporation, listed on NASDAQ under the symbol BRKR, is headquartered at 40 Manning Road, Billerica, Massachusetts.

The filing discloses that 1,410 shares were disposed of at a price of $57.02 per share on August 11, 2026. As stated in the explanation of responses, these shares represent amounts "withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person." Following this transaction, Herman directly holds 98,284 shares of Bruker common stock, with no indirect holdings reported. No derivative securities transactions were reported in Table II of the filing.

The statement was filed by one reporting person and was signed on August 13, 2026, by Betsy Eberg acting as Attorney-in-Fact for Herman. The filing was made pursuant to Section 16(a) of the Securities Exchange Act of 1934 and does not indicate that the transaction was made pursuant to a Rule 10b5-1(c) trading plan, as the corresponding checkbox was not selected.

What Was Disclosed

Bruker Corporation's CFO, Gerald N. Herman, disclosed a withholding of 1,410 common shares at $57.02 per share on August 11, 2026, to cover taxes on vested restricted stock units, leaving him with 98,284 directly held shares.